Phase II trial of gemcitabine/doxorubicin/paclitaxel administered every other week in patients with metastatic breast cancer.

1. Sánchez-Rovira, P.
2. Jaén, A.
3. González, E.
4. Porras, I.
5. Dueñas, M.R.
6. Medina, B.
7. Mohedano, N.
8. Fernández, M.
9. Martos, M.
10. Lozano, A.